|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu XY, Zheng RS, Sun KX, Zhang SW, Zeng
HM, Zou XN, Chen WQ and He J: Incidence and mortality of cervical
cancer in China, 2014. Zhonghua Zhong Liu Za Zhi. 40:241–246.
2018.(In Chinese). PubMed/NCBI
|
|
3
|
Kaidar-Person O, Bortnyak-Abdah R, Amit A,
Berniger A, Ben-Yosef R and Kuten A: Current principles for
radiotherapy in cervical cancer. Med Oncol. 29:2919–2922. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma S, Deep A and Sharma AK: Current
treatment for cervical cancer: An update. Anticancer Agents Med
Chem. 20:1768–1779. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diaz-Padilla I, Monk BJ, Mackay HJ and
Oaknin A: Treatment of metastatic cervical cancer: Future
directions involving targeted agents. Crit Rev Oncol Hematol.
85:303–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lefèvre A and Léonard P: Artesunate and
severe malaria in paediatrics. Rev Med Liege. 74:503–507.
2019.PubMed/NCBI
|
|
7
|
Abanyie F, Acharya SD, Leavy I, Bowe M and
Tan KR: Safety and effectiveness of intravenous artesunate for
treatment of severe malaria in the united States-April 2019 through
december 2020. Clin Infect Dis. 73:1965–1972. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roussel C, Ndour PA, Kendjo E, Larréché S,
Taieb A, Henry B, Lebrun-Vignes B, Chambrion C, Argy N, Houzé S, et
al: Intravenous artesunate for the treatment of severe imported
malaria: Implementation, efficacy, and safety in 1391 patients.
Clin Infect Dis. 73:1795–1804. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuda K, Miyamoto L, Hamano S, Morimoto Y,
Kangawa Y, Fukue C, Kagawa Y, Horinouchi Y, Xu W, Ikeda Y, et al:
Mechanisms of the pH- and Oxygen-dependent oxidation activities of
artesunate. Biol Pharmaceutical Bull. 41:555–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li T, Chen H, Liu XG, Zhou YX and Bai SF:
Immunoregulatory effect of artesunate on allergic contact
dermatitis and its mechanism. Yao Xue Xue Bao. 47:884–889.
2012.PubMed/NCBI
|
|
11
|
Meng QF, Zhang XX, Zhang Z, Chen W, Li XL,
Wang YJ, Li FF and Li YB: Therapeutic potential of artesunate in
experimental autoimmune myasthenia gravis by upregulated T
regulatory cells and regulation of Th1/Th2 cytokines. Pharmazie.
73:526–532. 2018.PubMed/NCBI
|
|
12
|
Wang N, Zeng GZ, Yin JL and Bian ZX:
Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects
ferroptosis in Burkitt's Lymphoma. Biochem Biophys Res Commun.
519:533–539. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang F, Zhou JY, Zhang D, Liu MH and Chen
YG: Artesunate induces apoptosis and autophagy in HCT116 colon
cancer cells, and autophagy inhibition enhances the
artesunate-induced apoptosis. Int J Mol Med. 42:1295–1304.
2018.PubMed/NCBI
|
|
14
|
Zhao F, Vakhrusheva O, Markowitsch SD,
Slade KS, Tsaur I, Cinatl J Jr, Michaelis M, Efferth T, Haferkamp A
and Juengel E: Artesunate impairs growth in cisplatin-resistant
bladder cancer cells by cell cycle arrest, apoptosis and autophagy
induction. Cells. 9:26432020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Gan S, Han L, Li X, Xie X, Zou D
and Sun H: Artesunate induces apoptosis and inhibits the
proliferation, stemness, and tumorigenesis of leukemia. Ann Transl
Med. 8:7672020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Våtsveen TK, Myhre MR, Steen CB, Wälchli
S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan
A, et al: Artesunate shows potent anti-tumor activity in B-cell
lymphoma. J Hematol Oncol. 11:232018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin X, Liu Y, Qin J, Wu Y, Huang J, Zhao
Q, Dang T, Tian Y, Yu P and Huang X: Artesunate suppresses the
proliferation and development of estrogen receptor-α-Positive
endometrial cancer in HAND2-Dependent pathway. Front Cell Dev Biol.
8:6069692020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mancuso RI, Foglio MA and Olalla Saad ST:
Artemisinin-type drugs for the treatment of hematological
malignancies. Cancer Chemother Pharmacol. 87:1–22. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu L, Zuo LF, Zuo J and Wang J:
Artesunate induces apoptosis and inhibits growth of Eca109 and
Ec9706 human esophageal cancer cell lines in vitro and in vivo. Mol
Med Rep. 12:1465–1472. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Liu L, Wang J and Chen Y:
Inhibitory effect of artesunate on growth and apoptosis of gastric
cancer cells. Arch Med Res. 48:623–630. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saeed MEM, Cives-Losada C and Efferth T:
Biomarker expression profiling in cervix carcinoma biopsies
unravels WT1 as a target of artesunate. Cancer Genomics Proteomics.
19:727–739. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Ju Y, Wang J and Zhou R:
Epigallocatechin-3-gallate promotes apoptosis and reversal of
multidrug resistance in esophageal cancer cells. Pathol Res Pract.
213:1242–1250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kriváková P, Cervinková Z, Lotková H,
Kucera O and Rousar T: Mitochondria and their role in cell
metabolism. Acta Medica (Hradec Kralove) Suppl. 48:57–67. 2005.(In
Czech). PubMed/NCBI
|
|
24
|
Estaquier J, Vallette F, Vayssiere JL and
Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med
Biol. 942:157–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lopez J and Tait SW: Mitochondrial
apoptosis: Killing cancer using the enemy within. Br J Cancer.
112:957–962. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeong SY and Seol DW: The role of
mitochondria in apoptosis. BMB Rep. 41:11–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaloni D, Diepstraten ST, Strasser A and
Kelly GL: BCL-2 protein family: Attractive targets for cancer
therapy. Apoptosis. 28:20–38. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kashyap D, Garg VK and Goel N: Intrinsic
and extrinsic pathways of apoptosis: Role in cancer development and
prognosis. Adv Protein Chem Struct Biol. 125:73–120. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Ju Y, Liu J, Chen Y, Huo X and Liu
L: Inhibition of proliferation and migration and induction of
apoptosis in glioma cells by silencing TLR4 expression levels via
RNA interference. Oncol Lett. 21:132021.PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hafezi S and Rahmani M: Targeting BCL-2 in
cancer: Advances, challenges, and perspectives. Cancers (Basel).
13:12922021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wen L, Lv G, Zhao J, Lu S, Gong Y, Li Y,
Zheng H, Chen B, Gao H, Tian C and Wang J: In vitro and in vivo
effects of artesunate on echinococcus granulosus protoscoleces and
metacestodes. Drug Des Devel Ther. 14:4685–4694. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Ni W, Deng Z, Liu M, She L and Xie
Q: Targeting nasopharyngeal carcinoma by artesunate through
inhibiting Akt/mTOR and inducing oxidative stress. Fundam Clin
Pharmacol. 31:301–310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abate M, Festa A, Falco M, Lombardi A,
Luce A, Grimaldi A, Zappavigna S, Sperlongano P, Irace C, Caraglia
M and Misso G: Mitochondria as playmakers of apoptosis, autophagy
and senescence. Semin Cell Dev Bio. 98:139–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Cui J, Li Z, Fu X, Li J, Li H, Wang
S and Zhang M: ORP8 induces apoptosis by releasing cytochrome c
from mitochondria in non-small cell lung cancer. Oncol Rep.
43:1516–1524. 2020.PubMed/NCBI
|
|
37
|
Wang W, Zhu M, Xu Z, Li W, Dong X, Chen Y,
Lin B and Li M: Ropivacaine promotes apoptosis of hepatocellular
carcinoma cells through damaging mitochondria and activating
caspase-3 activity. Biol Res. 52:362019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu
J, Cai Y, Huang S, He N, Hu Z and Jin X: Artesunate induces
autophagy dependent apoptosis through upregulating ROS and
activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem
Biol Interact. 331:1092732020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ji P, Huang H, Yuan S, Wang L, Wang S,
Chen Y, Feng N, Veroniaina H, Wu Z, Wu Z and Qi X: ROS-mediated
apoptosis and anticancer effect achieved by artesunate and
auxiliary fe(II) released from ferriferous Oxide-Containing
recombinant apoferritin. Adv Healthc Mater. 8:e19009112019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greenshields AL, Fernando W and Hoskin DW:
The anti-malarial drug artesunate causes cell cycle arrest and
apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3
breast cancer cells. Exp Mol Pathol. 107:10–22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang Z, Gan S, Zhuang X, Chen Y, Lu L,
Wang Y, Qi X, Feng Q, Huang Q, Du B, et al: Artesunate Inhibits the
cell growth in colorectal cancer by promoting ROS-Dependent cell
senescence and autophagy. Cells. 11:24722022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qian S, Wei Z, Yang W, Huang J, Yang Y and
Wang J: The role of BCL-2 family proteins in regulating apoptosis
and cancer therapy. Front Oncol. 12:9853632022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Holien T, Olsen OE, Misund K, Hella H,
Waage A, Rø TB and Sundan A: Lymphoma and myeloma cells are highly
sensitive to growth arrest and apoptosis induced by artesunate. Eur
J Haematol. 91:339–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao D, Chen D, Xia JN, Wang WY, Zhu GY,
Chen LW, Zhang C, Tan B, Li H and Li YW: Artesunate promoted
anti-tumor immunity and overcame EGFR-TKI resistance in
non-small-cell lung cancer by enhancing oncogenic TAZ degradation.
Biomed Pharmacothe. 155:1137052022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH,
Wang ZX, Yang XM, Liu YJ, Wu Y, Chen PH, et al: Artesunate
synergizes with sorafenib to induce ferroptosis in hepatocellular
carcinoma. Acta Pharmacol Sin. 42:301–310. 2021. View Article : Google Scholar : PubMed/NCBI
|
